|
Video: What is a Stock Split?
|
|
CureVac is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company developing medicines based on messenger ribonucleic acid (mRNA). Co.'s product portfolio includes clinical and preclinical candidates in prophylactic vaccines, oncology and molecular therapy. In prophylactic vaccines, Co. is developing its mRNA vaccine candidate, CV2CoV against coronavirus (SARS-CoV-2) in collaboration with GlaxoSmithKline Biologicals SA. CV2CoV is a representative of its COVID-19 vaccine program. The vaccine candidate is a non-chemically modified mRNA, encoding the prefusion stabilized full-length spike protein of the SARS-CoV-2 virus, and formulated within Lipid Nanoparticles. According to our CureVac stock split history records, CureVac has had 1 split. | |
|
CureVac (CVAC) has 1 split in our CureVac stock split history database. The split for CVAC took place on November 14, 2008. This was a 1 for 1000 reverse split, meaning for each 1000 shares of CVAC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 1 share position following the split.
When a company such as CureVac conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CureVac stock split history from start to finish, an original position size of 1000 shares would have turned into 1 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CureVac shares, starting with a $10,000 purchase of CVAC, presented on a split-history-adjusted basis factoring in the complete CureVac stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/17/2020 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$77.20 |
|
End price/share: |
$3.13 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-95.95% |
|
Average Annual Total Return: |
-57.83% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$405.41 |
|
Years: |
3.71 |
|
|
|
Date |
Ratio |
11/14/2008 | 1 for 1000 |
|
|